Extract of oregano, coffee, thyme, clove, and walnuts inhibits NF-κB in monocytes and in transgenic reporter mice

Cancer Prevention Research

Volumn 3, Issue 5, 2010, Pages 653-663

  Paur, Ingvild ^a   Balstad, Trude R ^a   Kolberg, Marit ^a   Pedersen, Marit K ^a   Austenaa, Liv M ^b   Jacobs Jr , David R ^a,c   Blomhoff, Rune ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOVE EXTRACT; COFFEE EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; OREGANO EXTRACT; PLANT EXTRACT; THYME EXTRACT; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; WALNUT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; EPIDIDYMIS; FEMALE; GENE EXPRESSION; INFLAMMATION; INTESTINE; LIVER; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TESTIS; TRANSGENIC MOUSE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COFFEE; ENZYME ACTIVATION; EUGENIA; GENE EXPRESSION; HUMANS; INFLAMMATION; JUGLANS; MICE; MICE, TRANSGENIC; MONOCYTES; NF-KAPPA B; ORIGANUM; PHYTOTHERAPY; PLANT EXTRACTS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; SIGNAL TRANSDUCTION; THYMUS PLANT;

EID: 77952035470     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0089     Document Type: Article

References (51)

1. Greten FR, Karin M. The IKK/NF-κB activation pathway-a target for prevention and treatment of cancer. Cancer Lett 2004;206:193-199 (Pubitemid 38317289)
2. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression. Cancer Cell 2004;6:297-305. (Pubitemid 39222042)
3. Pikarsky E, Porat RM, Stein I, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431:461-466 (Pubitemid 39329586)
4. Karin M, Yamamoto Y, Wang QM. The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov 2004;3:17-26. (Pubitemid 38088695)
5. Valen G, Yan ZQ, Hansson GK. Nuclear factor κ-B and the heart. J Am Coll Cardiol 2001;38:307-314
6. Mattson MP, Camandola S. NF-κB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001;107:247-254 (Pubitemid 32162153)
7. Neurath MF, Becker C, Barbulescu K. Role of NF-κB in immune and inflammatory responses in the gut. Gut 1998;43:856-860 (Pubitemid 28539668)
8. Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002;2:301-310 (Pubitemid 37328783)
9. Colombo MP, Mantovani A. Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion. Cancer Res 2005;65:9113-9116 (Pubitemid 41507968)
10. Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005;121:977-990 (Pubitemid 40884391)
11. Bonizzi G, Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004;25:280-288 (Pubitemid 38610351)
12. Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999;18:6853-6866
13. Karin M, Greten FR. NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005;5:749-759 (Pubitemid 41400849)
14. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003;3:768-780
15. Nakanishi C, Toi M. Nuclear factor-κB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 2005;5:297-309. (Pubitemid 40488635)
16. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79:727-747
17. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington (DC): AICR; 2007.
18. FAO/WHO. Joint FAO/WHO Expert Report on Diet, Nutrition and the Prevention of Chronic Disease. WHO Technical Report Series; 2003. Report No.: 916.
19. Bjelakovic G, Nikolova D, Ll G, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2008; Jul 16:CD004183.
20. Paur I, Austenaa LM, Blomhoff R. Extracts of dietary plants are efficient modulators of nuclear factor κ B. Food Chem Toxicol 2008;46:1288-1297 (Pubitemid 351258206)
21. Carlsen H, Moskaug JO, Fromm SH, Blomhoff R. In vivo imaging of NF-κ B activity. J Immunol 2002;168:1441-1446
22. Myhrstad MC, Carlsen H, Dahl LI, et al. Bilberry extracts induce gene expression through the electrophile response element. Nutr Cancer 2006;54:94-101. (Pubitemid 44141340)
23. Liu GH, Qu J, Shen X. NF-κB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim Biophys Acta 2008;1783:713-727
24. Li W, Khor TO, Xu C, et al. Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis. Biochem Pharmacol 2008;76:1485-1489
25. Surh YJ, Na HK. NF-κB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. Genes Nutr 2008;2:313-317
26. Park JM, Greten FR, Wong A, et al. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-κB as key regulators. Immunity 2005;23:319-329 (Pubitemid 41319727)
27. Elsharkawy AM, Mann DA. Nuclear factor-κB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 2007;46:590-597
28. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology 1997;26:34-8S.
29. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006;43:S54-62.
30. Maeda S, Hikiba Y, Sakamoto K, et al. Iκ B kinase/nuclear factor-B activation controls the development of liver metastasis by way of interleukin-6 expression. Hepatology 2009;50:1851-1860
31. Imhof BA, Aurrand-Lions M. Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol 2004;4:432-444 (Pubitemid 38745555)
32. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008;8:533-544
33. Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H. Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998;19:1771-1776
34. Mullen W, Graf BA, Caldwell ST, et al. Determination of flavonol metabolites in plasma and tissues of rats by HPLC-radiocounting and tandem mass spectrometry following oral ingestion of [2-(14)C]-quercetin-4′-glucoside. J Agric Food Chem 2002;50:6902-6909
35. Vitrac X, Desmouliere A, Brouillaud B, et al. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 2003;72:2219-2233
36. Dinkova-Kostova AT, Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 2008;52 Suppl 1:S128-38.
37. Ramos-Gomez M, Kwak MK, Dolan PM, et al. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci U S A 2001;98:3410-3415 (Pubitemid 32220859)
38. Khor TO, Huang MT, Prawan A, et al. Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer. Cancer Prev Res 2008;1:187-191
39. Xu W, Hellerbrand C, Kohler UA, et al. The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis. Lab Invest 2008;88:1068-1078
40. Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005;129:1928-1936
41. Larsson SC, Wolk A. Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology 2007;132:1740-1745 (Pubitemid 46677953)
42. Andersen LF, Jacobs DR, Jr., Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 2006;83:1039-1046 (Pubitemid 44713102)
43. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436-444
44. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276-285
45. Dragland S, Senoo H, Wake K, Holte K, Blomhoff R. Several culinary and medicinal herbs are important sources of dietary antioxidants. J Nutr 2003;133:1286-1290 (Pubitemid 36553084)
46. Halvorsen BL, Holte K, Myhrstad MC, et al. A systematic screening of total antioxidants in dietary plants. J Nutr 2002;132: 461-471 (Pubitemid 34208750)
47. Lee J, Jung E, Kim Y, et al. Rosmarinic acid as a downstream inhibitor of IKK-β in TNF-α-induced upregulation of CCL11 and CCR3. Br J Pharmacol 2006;148:366-375 (Pubitemid 43801183)
48. Chainy GB, Manna SK, Chaturvedi MM, Aggarwal BB. Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-κB, AP-1, JNK, MAPKK and apoptosis. Oncogene 2000;19:2943-2950
49. Bukovska A, Cikos S, Juhas S, Il'kova G, Rehak P, Koppel J. Effects of a combination of thyme and oregano essential oils on TNBS-induced colitis in mice. Mediators Inflamm 2007;2007:23296.
50. Sasaki K, Wada K, Tanaka Y, Yoshimura T, Matuoka K, Anno T. Thyme (Thymus vulgaris L.) leaves and its constituents increase the activities of xenobiotic-metabolizing enzymes in mouse liver. J Med Food 2005;8:184-189 (Pubitemid 41008981)
51. Ros E, Mataix J. Fatty acid composition of nuts-implications for cardiovascular health. Br J Nutr 2006;96 Suppl 2:S29-35.